NO308528B1 - Substituerte 1-naftoylguanidiner, deres anvendelse for fremstilling av medikamenter samt helbredende middel inneholdende forbindelsene - Google Patents

Substituerte 1-naftoylguanidiner, deres anvendelse for fremstilling av medikamenter samt helbredende middel inneholdende forbindelsene

Info

Publication number
NO308528B1
NO308528B1 NO972434A NO972434A NO308528B1 NO 308528 B1 NO308528 B1 NO 308528B1 NO 972434 A NO972434 A NO 972434A NO 972434 A NO972434 A NO 972434A NO 308528 B1 NO308528 B1 NO 308528B1
Authority
NO
Norway
Prior art keywords
naphthoylguanidines
medicaments
substituted
compounds
manufacture
Prior art date
Application number
NO972434A
Other languages
English (en)
Norwegian (no)
Other versions
NO972434D0 (no
NO972434L (no
Inventor
Joachim Brendel
Heinz-Werner Kleemann
Heinrich Christian Englert
Hans Jochen Lang
Udo Albus
Bansi Lal
Anil Vasantrao Ghate
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO972434D0 publication Critical patent/NO972434D0/no
Publication of NO972434L publication Critical patent/NO972434L/no
Publication of NO308528B1 publication Critical patent/NO308528B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO972434A 1996-05-29 1997-05-28 Substituerte 1-naftoylguanidiner, deres anvendelse for fremstilling av medikamenter samt helbredende middel inneholdende forbindelsene NO308528B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19621482A DE19621482A1 (de) 1996-05-29 1996-05-29 Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (3)

Publication Number Publication Date
NO972434D0 NO972434D0 (no) 1997-05-28
NO972434L NO972434L (no) 1997-12-01
NO308528B1 true NO308528B1 (no) 2000-09-25

Family

ID=7795548

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972434A NO308528B1 (no) 1996-05-29 1997-05-28 Substituerte 1-naftoylguanidiner, deres anvendelse for fremstilling av medikamenter samt helbredende middel inneholdende forbindelsene

Country Status (29)

Country Link
US (1) US6600072B2 (es)
EP (1) EP0810205B1 (es)
JP (1) JP4039587B2 (es)
KR (1) KR970074753A (es)
CN (1) CN1062859C (es)
AR (1) AR007299A1 (es)
AT (1) ATE200076T1 (es)
AU (1) AU710258B2 (es)
BR (1) BR9703342A (es)
CA (1) CA2206362C (es)
CZ (1) CZ292441B6 (es)
DE (2) DE19621482A1 (es)
DK (1) DK0810205T3 (es)
ES (1) ES2155223T3 (es)
GR (1) GR3035811T3 (es)
HR (1) HRP970294B1 (es)
HU (1) HUP9700954A3 (es)
ID (1) ID17348A (es)
IL (1) IL120925A0 (es)
NO (1) NO308528B1 (es)
NZ (1) NZ314914A (es)
PL (1) PL185755B1 (es)
PT (1) PT810205E (es)
RU (1) RU2182901C2 (es)
SI (1) SI0810205T1 (es)
SK (1) SK282356B6 (es)
TR (1) TR199700427A2 (es)
TW (1) TW372955B (es)
ZA (1) ZA974664B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19621483A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
AR039156A1 (es) * 2002-03-28 2005-02-09 Novartis Ag Amidas del acido piperidinilamino sulfamico o piperazinil sulfamico y su uso para la manufactura de un medicamento en enfermedades mediadas por la accion de la sulfatasa esteroide
AU2003297629A1 (en) * 2002-12-04 2004-06-23 Ore Pharmaceuticals Inc. Modulators of melanocortin receptor
KR101153254B1 (ko) * 2003-06-26 2012-07-02 바이오트론 리미티드 항바이러스 화합물 및 방법
US20110118262A1 (en) * 2008-07-08 2011-05-19 Boehringer Ingelheim International Gmbh Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251545A (en) * 1979-09-19 1981-02-17 Gaf Corporation Fungicidal process using 1-(alkoxyaroyl)guanidines
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4415873A1 (de) 1994-05-05 1995-11-09 Hoechst Ag Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JPH08225513A (ja) * 1994-12-21 1996-09-03 Kanebo Ltd ナフトイルグアニジン誘導体
JPH08225135A (ja) 1995-02-21 1996-09-03 Mitsubishi Heavy Ind Ltd スクリユ−式土砂搬送機
DE19621483A1 (de) 1996-05-29 1997-12-04 Hoechst Ag Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
AR007299A1 (es) 1999-10-27
KR970074753A (ko) 1997-12-10
CA2206362A1 (en) 1997-11-29
HRP970294B1 (en) 2002-02-28
SK282356B6 (sk) 2002-01-07
JPH1081663A (ja) 1998-03-31
PL318724A1 (en) 1997-12-08
HUP9700954A3 (en) 1998-04-28
NO972434D0 (no) 1997-05-28
US20030013760A1 (en) 2003-01-16
BR9703342A (pt) 1998-08-18
EP0810205A1 (de) 1997-12-03
MX9703921A (es) 1997-11-29
JP4039587B2 (ja) 2008-01-30
EP0810205B1 (de) 2001-03-28
RU2182901C2 (ru) 2002-05-27
CZ163197A3 (cs) 1998-06-17
HUP9700954A2 (hu) 1998-03-02
SK66997A3 (en) 1997-12-10
DE59703220D1 (de) 2001-05-03
CN1167758A (zh) 1997-12-17
ZA974664B (en) 1997-12-01
CA2206362C (en) 2007-11-20
DK0810205T3 (da) 2001-07-16
HRP970294A2 (en) 1998-04-30
US6600072B2 (en) 2003-07-29
CZ292441B6 (cs) 2003-09-17
NZ314914A (en) 1998-02-26
ES2155223T3 (es) 2001-05-01
ID17348A (id) 1997-12-24
GR3035811T3 (en) 2001-07-31
IL120925A0 (en) 1997-09-30
AU2371397A (en) 1997-12-04
PT810205E (pt) 2001-08-30
TW372955B (en) 1999-11-01
SI0810205T1 (es) 2001-06-30
TR199700427A2 (xx) 1997-12-21
DE19621482A1 (de) 1997-12-04
CN1062859C (zh) 2001-03-07
HU9700954D0 (en) 1997-07-28
AU710258B2 (en) 1999-09-16
NO972434L (no) 1997-12-01
ATE200076T1 (de) 2001-04-15
PL185755B1 (pl) 2003-07-31

Similar Documents

Publication Publication Date Title
NO984852L (no) Nye benzazepinderivater, medikamenter inneholdende forbindelsene samt deres anvendelse ved fremstilling av medikamentene
EE9700043A (et) Asendatud oksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE9700031A (et) Pürido-liitunud tienüül- ja furanüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE9700044A (et) Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid.
NO304488B1 (no) 5-leddede heteroaryloksazolidinoner, anvendelse av disse for fremstilling av legemidler samt legemiddel inneholdende forbindelsen
NO20021714D0 (no) 2-fenyl-substituerte imidazotriazinoner, fremgangsmåte for fremstilling derav samt anvendelse av forbindelsene
NO952618D0 (no) Xerogeler, fremgangsmåte for fremstilling derav samt deres anvendelse
NO990793L (no) 7<alfa>-(<Epsilon>-aminoalkyl)-°stratriener, fremgangsmÕte for fremstilling av disse, farmas°ytiske preparater inneholdende disse, samt deres anvendelse for fremstilling av legemidler
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
NO952493D0 (no) Pyrrolidin- og tiazolidinderivater, deres fremstilling samt medikamenter inneholdende forbindelsene
EE9700153A (et) Heterotsükliga kondenseerunud püridiinid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE9700019A (et) 2-okso- ja 2-tio1,2-dihüdrokinolinüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
NO890361L (no) Polymert materiale, fremgangsmaate for dets fremstilling, samt anvendelse av materialet.
NO996269D0 (no) Quinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
NO974375D0 (no) Stötfanger, samt tilvirkning av samme
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
NO952651D0 (no) Absorberende gjenstand av bleie-eller innleggstypen samt innlegg dertil
NO971811D0 (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
NO308287B1 (no) Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
NO308527B1 (no) Substituerte 2-naftoylguanidiner, deres anvendelse for fremstilling av et medikament samt legemidler og preparater inneholdende forbindelsene
DE59707096D1 (de) Haarbehandlungsmittel zur Festigung der Haare
NO305948B1 (no) Basisk substituerte benzolguanidiner, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikament inneholdende forbindelsen
EE03193B1 (et) (1-heteroasolüül-1-heterotsüklüül)alkaani derivaadid, nende saamise protsessid ja nende kasutamine närvisüsteemi kaitsvate vahendite valmistamiseks
EE03690B1 (et) Imidasopüridasiinid, neid sisaldav ravim ja nendekasutamine

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees